Therapeutic Use of Infliximab in Tuberculosis to Control Severe Paradoxical Reaction of the Brain and Lymph Nodes
Open Access
- 15 November 2008
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 47 (10) , e83-e85
- https://doi.org/10.1086/592695
Abstract
Paradoxical reactions are immune-mediated exacerbations of disease triggered by tuberculosis treatment. Paradoxical reactions involving the central nKeywords
This publication has 11 references indexed in Scilit:
- Mathematical modeling of the cause of tuberculosis during tumor necrosis factor blockadeArthritis & Rheumatism, 2008
- Neutralization of Tumor Necrosis Factor (TNF) by Antibody but not TNF Receptor Fusion Molecule Exacerbates Chronic Murine TuberculosisThe Journal of Infectious Diseases, 2007
- Intractable Intracranial Tuberculous Infection Responsive to Thalidomide: Report of Four CasesJournal of Child Neurology, 2006
- Paradoxical Reaction during Tuberculosis Treatment in HIV-Seronegative PatientsClinical Infectious Diseases, 2006
- Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patientsAIDS, 2006
- Immunoadjuvant Prednisolone Therapy for HIV‐Associated Tuberculosis: A Phase 2 Clinical Trial in UgandaThe Journal of Infectious Diseases, 2005
- Paradoxical Response to Antituberculous Therapy in Infliximab-Treated Patients with Disseminated TuberculosisClinical Infectious Diseases, 2005
- Adjunctive Thalidomide Therapy for Childhood Tuberculous Meningitis: Results of a Randomized StudyJournal of Child Neurology, 2004
- A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosisAIDS, 2004
- Paradoxical Enlargement or Development of Intracranial Tuberculomas During Therapy: Case Report and ReviewClinical Infectious Diseases, 1994